Research and development of increased cell energy potential by streamlining glycolysis processes and oxidative phosphorylation with standardised glycaemic regulation (Q11293)

From EU Knowledge Graph
Revision as of 20:40, 27 December 2020 by DG Regio (talk | contribs) (‎Changed an Item: Change because item Q214249 was merged with Q4869)
Jump to navigation Jump to search
Project Q11293 in Czech Republic
Language Label Description Also known as
English
Research and development of increased cell energy potential by streamlining glycolysis processes and oxidative phosphorylation with standardised glycaemic regulation
Project Q11293 in Czech Republic

    Statements

    0 references
    11,688,887.0 Czech koruna
    0 references
    467,555.48 Euro
    10 January 2020
    0 references
    16,698,410.0 Czech koruna
    0 references
    667,936.4 Euro
    10 January 2020
    0 references
    70 percent
    0 references
    2 January 2018
    0 references
    31 December 2019
    0 references
    Euro Enterprise Development s.r.o.
    0 references
    0 references

    49°35'41.89"N, 17°16'31.12"E
    0 references
    77900
    0 references
    Hlavním cílem řešení projektu je realizace průmyslového výzkumu a experimentálního vývoje v konsorciu složeném ze soukromého subjektu (hlavní žadatel) Euro Enterprise Development s. r. o. a veřejného subjektu (ostatní žadatel) Univerzity Palackého v Olomouci, Lékařské fakulty. Konkrétní podporovaný výsledek bude užitný vzor na světově unikátní recepturu, která dokáže zastabilizovat hladinu glukózy v lidském organismu a tak optimalizovat inzulínovou reakci. a. (Czech)
    0 references
    The main objective of the project is to implement industrial research and experimental development in a consortium consisting of a private entity (main applicant) Euro Enterprise Development s. r. o. and public body (other applicant) of Palacký University Olomouc, Faculty of Medicine. The specific supported result will be a useful pattern in the world’s unique formula, which can stabilise the level of glucose in the human body and thus optimise the insulin response. a. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/16_084/0010288
    0 references